ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01245166
Recruitment Status : Unknown
Verified November 2010 by Lotus Pharmaceutical.
Recruitment status was:  Recruiting
First Posted : November 22, 2010
Last Update Posted : November 22, 2010
Sponsor:
Information provided by:
Lotus Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2011
  Estimated Study Completion Date : December 2011